US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Theriva Biologics

0.2023

-0.0215-9.61%

Post-market: 0.2012-0.0011-0.54%19:59 EDT

Volume:2.89M

Turnover:602.44K

Market Cap:9.28M

PE:-0.10

High:0.2203

Open:0.2189

Low:0.2005

Close:0.2238

52wk High:1.50

52wk Low:0.1628

Shares:45.89M

Float Shares:45.14M

Volume Ratio:0.05

T/O Rate:6.41%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.0797

EPS(LYR):-19.0286

ROE:-137.82%

ROA:-25.51%

PB:0.60

PE(LYR):-0.01

Loading ...

Overview Company News Filings

Theriva™ Biologics Announces Positive Scientific Advice From the European Medicines Agency (Ema) on the Design of a Phase 3 Trial of Vcn-01 in Metastatic Pancreatic Ductal Adenocarcinoma (Pdac)

THOMSON REUTERS

Theriva Biologics Inc - to Schedule End-of-Phase 2 Meeting With FDA in H1 2026

THOMSON REUTERS

Theriva Biologics Seeks Shareholder Approval for Issuance of 16.2 Million Shares Under Warrant Agreement

Theriva Biologics reports Q3 EPS (45c) vs ($6.81) last year

Theriva Biologics Q3 EPS $(0.45) Beats $(1.13) Estimate

Theriva Biologics reports third quarter loss and lower R&D expenses

Theriva Biologics Inc. Announces Date for Upcoming Special Stockholders Meeting

Theriva Biologics: No Material Development to Account for Stock Activity

Theriva Biologics sees no material development to account for unusual trading

Theriva Biologics Provides Response to Unusual Market Action

Theriva Biologics Presents Promising Phase 2b Trial Data

Theriva Biologics Secures $4M Through Warrant Agreement

Theriva Biologics Raises $4 Million Through Warrant Inducement Private Placement

Theriva Biologics announces warrant inducement transaction for $4M in proceeds

Theriva Biologics Announces New Preclinical Data and Next-Generation Oncolytic Adenovirus VCN-12 at ESGCT Congress, Highlighting Advances in Cancer Treatment

Theriva Biologics Restructures, Cuts Workforce by 32%

BRIEF-Theriva Biologics Implements 32% Workforce Reduction - SEC Filing

Theriva Biologics Inc: Expects Will Extend Its Cash Runway Into Q2 of 2026

THOMSON REUTERS

Theriva Biologics Announces Corporate Reorganization, Cuts Workforce by 32% to Focus on Clinical Trials and Licensing Activities

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/TOVX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TOVX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TOVX\",,,,,undefined,":{"symbol":"TOVX","market":"US","secType":"STK","nameCN":"Theriva Biologics","latestPrice":0.2023,"timestamp":1774641600000,"preClose":0.2238,"halted":0,"volume":2894048,"hourTrading":{"tag":"盘后","latestPrice":0.2012,"preClose":0.2023,"latestTime":"19:59 EDT","volume":102073,"amount":20756.88429,"timestamp":1774655969799,"change":-0.0011,"changeRate":-0.005437,"amplitude":0.045477},"delay":0,"changeRate":-0.09606791778373544,"floatShares":45143400,"shares":45892668,"eps":-2.079699,"marketStatus":"Not Yet Opened","change":-0.0215,"latestTime":"03-27 16:00:00 EDT","open":0.2189,"high":0.2203,"low":0.2005,"amount":602441.87503936,"amplitude":0.088472,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-2.079699,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":0,"adr":0,"exchange":"AMEX","adjPreClose":0.2238,"preHourTrading":{"tag":"盘前","latestPrice":0.2224,"preClose":0.2238,"latestTime":"09:28 EDT","volume":187968,"amount":40351.545442560004,"timestamp":1774618130883,"change":-0.0014,"changeRate":-0.006256,"amplitude":0.050045},"postHourTrading":{"tag":"盘后","latestPrice":0.2012,"preClose":0.2023,"latestTime":"19:59 EDT","volume":102073,"amount":20756.88429,"timestamp":1774655969799,"change":-0.0011,"changeRate":-0.005437,"amplitude":0.045477},"volumeRatio":0.04877080142813654},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TOVX\",,,,,undefined,":{"symbol":"TOVX","floatShares":45143400,"roa":"-25.51%","roe":"-137.82%","lyrEps":-19.028636,"volumeRatio":0.04877080142813654,"shares":45892668,"dividePrice":0,"high":0.2203,"amplitude":0.088472,"preClose":0.2238,"low":0.2005,"week52Low":0.1628,"pbRate":"0.60","week52High":1.5,"institutionHeld":0.0648,"latestPrice":0.2023,"eps":-2.079699,"divideRate":0,"volume":2894048,"delay":0,"ttmEps":-2.079699,"open":0.2189,"prevYearClose":0.2104,"prevWeekClose":0.1937,"prevMonthClose":0.2,"prevQuarterClose":0.2104,"fiveDayClose":0.1937,"twentyDayClose":0.2,"sixtyDayClose":0.196},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TOVX\",params:#limit:5,,,undefined,":[{"date":"2026-03-12","symbol":"TOVX","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/12","expectedEps":null,"defaultRemindTime":1773302400000,"name":null,"time":"Pre-Market","dateTimestamp":1773288000000,"actualEps":null},{"market":"US","date":"2025-11-12","symbol":"TOVX","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.45},{"market":"US","date":"2025-08-11","symbol":"TOVX","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"pre","actualEps":-1.93},{"market":"US","date":"2025-05-14","symbol":"TOVX","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"pre","actualEps":-1.55},{"market":"US","date":"2025-03-06","symbol":"TOVX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741237200000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TOVX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TOVX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.5,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":2,"updateTime":1746849600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TOVX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TOVX","date":"2026-03-27","current":-0.097274,"percent":0.519967,"low":-9.88774,"twenty":-2.899148,"median":-0.457248,"eighty":-0.161746,"high":-0.056131,"avg":-1.601104,"sd":2.297917,"marketCap":10270779},"quantilePoints":[{"date":"2021-04-01","current":-9.172515,"twenty":-2.018737,"median":-0.673998,"eighty":-0.513578,"marketCap":92119571},{"date":"2021-04-09","current":-8.350152,"twenty":-2.051112,"median":-0.674717,"eighty":-0.514159,"marketCap":83860575},{"date":"2021-04-16","current":-6.848725,"twenty":-2.094781,"median":-0.676918,"eighty":-0.514473,"marketCap":68781749},{"date":"2021-04-23","current":-6.988153,"twenty":-2.163613,"median":-0.679881,"eighty":-0.515344,"marketCap":70182018},{"date":"2021-04-30","current":-7.397398,"twenty":-2.194867,"median":-0.682767,"eighty":-0.518561,"marketCap":74292068},{"date":"2021-05-07","current":-7.1178,"twenty":-2.221908,"median":-0.686065,"eighty":-0.521927,"marketCap":68437643},{"date":"2021-05-14","current":-6.893952,"twenty":-2.267386,"median":-0.689255,"eighty":-0.524028,"marketCap":66285350},{"date":"2021-05-21","current":-7.345767,"twenty":-2.382748,"median":-0.691482,"eighty":-0.52724,"marketCap":70629549},{"date":"2021-05-28","current":-7.209811,"twenty":-2.521272,"median":-0.694092,"eighty":-0.528064,"marketCap":69322328},{"date":"2021-06-04","current":-7.998083,"twenty":-2.564004,"median":-0.698842,"eighty":-0.528337,"marketCap":76901569},{"date":"2021-06-11","current":-8.930552,"twenty":-2.625887,"median":-0.7006,"eighty":-0.529142,"marketCap":85867257},{"date":"2021-06-18","current":-8.465004,"twenty":-2.675965,"median":-0.703205,"eighty":-0.532548,"marketCap":81391015},{"date":"2021-06-25","current":-8.418312,"twenty":-2.697237,"median":-0.703748,"eighty":-0.536469,"marketCap":80942070},{"date":"2021-07-02","current":-7.840154,"twenty":-2.73128,"median":-0.706976,"eighty":-0.536909,"marketCap":75383080},{"date":"2021-07-09","current":-7.511936,"twenty":-2.769358,"median":-0.711202,"eighty":-0.538469,"marketCap":72227263},{"date":"2021-07-16","current":-6.797821,"twenty":-2.77377,"median":-0.713147,"eighty":-0.539533,"marketCap":65361052},{"date":"2021-07-23","current":-7.344394,"twenty":-2.836508,"median":-0.715896,"eighty":-0.540326,"marketCap":70616345},{"date":"2021-07-30","current":-7.171358,"twenty":-2.882453,"median":-0.717756,"eighty":-0.541347,"marketCap":68952609},{"date":"2021-08-06","current":-6.637318,"twenty":-2.948541,"median":-0.718104,"eighty":-0.541544,"marketCap":65994856},{"date":"2021-08-13","current":-6.246888,"twenty":-3.050215,"median":-0.718832,"eighty":-0.541903,"marketCap":62112806},{"date":"2021-08-20","current":-5.906921,"twenty":-3.095202,"median":-0.725362,"eighty":-0.542403,"marketCap":58732517},{"date":"2021-08-27","current":-6.452727,"twenty":-3.130706,"median":-0.729547,"eighty":-0.542403,"marketCap":64159465},{"date":"2021-09-03","current":-6.726294,"twenty":-3.178396,"median":-0.729686,"eighty":-0.542403,"marketCap":66879541},{"date":"2021-09-10","current":-6.798006,"twenty":-3.194253,"median":-0.732303,"eighty":-0.542403,"marketCap":67592571},{"date":"2021-09-17","current":-6.382343,"twenty":-3.213982,"median":-0.741153,"eighty":-0.542537,"marketCap":63459639},{"date":"2021-09-24","current":-6.566935,"twenty":-3.278986,"median":-0.742349,"eighty":-0.54297,"marketCap":65295031},{"date":"2021-10-01","current":-6.030425,"twenty":-3.304661,"median":-0.747481,"eighty":-0.543109,"marketCap":59960512},{"date":"2021-10-08","current":-5.617418,"twenty":-3.334322,"median":-0.752374,"eighty":-0.543701,"marketCap":55853990},{"date":"2021-10-15","current":-5.772794,"twenty":-3.345181,"median":-0.752851,"eighty":-0.544169,"marketCap":57398887},{"date":"2021-10-22","current":-5.391659,"twenty":-3.400752,"median":-0.754125,"eighty":-0.544316,"marketCap":53609267},{"date":"2021-10-29","current":-5.492587,"twenty":-3.745956,"median":-0.764317,"eighty":-0.544913,"marketCap":54612790},{"date":"2021-11-05","current":-4.992736,"twenty":-4.551182,"median":-0.764433,"eighty":-0.545058,"marketCap":55484271},{"date":"2021-11-12","current":-4.65054,"twenty":-4.730623,"median":-0.768317,"eighty":-0.546509,"marketCap":51681446},{"date":"2021-11-19","current":-4.277451,"twenty":-4.687373,"median":-0.770925,"eighty":-0.546872,"marketCap":47535310},{"date":"2021-11-26","current":-4.063578,"twenty":-4.671179,"median":-0.774385,"eighty":-0.547752,"marketCap":45158545},{"date":"2021-12-03","current":-3.680984,"twenty":-4.657329,"median":-0.786323,"eighty":-0.548571,"marketCap":40906775},{"date":"2021-12-10","current":-3.868717,"twenty":-4.641812,"median":-0.787309,"eighty":-0.548963,"marketCap":42993047},{"date":"2021-12-17","current":-3.847329,"twenty":-4.627611,"median":-0.788987,"eighty":-0.549663,"marketCap":42755371},{"date":"2021-12-23","current":-3.938225,"twenty":-4.585205,"median":-0.79918,"eighty":-0.550108,"marketCap":43765496},{"date":"2021-12-31","current":-3.234228,"twenty":-4.516893,"median":-0.803705,"eighty":-0.55026,"marketCap":35941976},{"date":"2022-01-07","current":-3.301954,"twenty":-4.470466,"median":-0.810762,"eighty":-0.551195,"marketCap":36694619},{"date":"2022-01-14","current":-3.132044,"twenty":-4.416951,"median":-0.818396,"eighty":-0.552757,"marketCap":34806410},{"date":"2022-01-21","current":-2.977581,"twenty":-4.382338,"median":-0.823792,"eighty":-0.553146,"marketCap":33089858},{"date":"2022-01-28","current":-2.756579,"twenty":-4.314522,"median":-0.839718,"eighty":-0.55352,"marketCap":30633866},{"date":"2022-02-04","current":-2.817177,"twenty":-4.277451,"median":-0.860023,"eighty":-0.554015,"marketCap":31307283},{"date":"2022-02-11","current":-3.114222,"twenty":-4.269229,"median":-0.879323,"eighty":-0.554319,"marketCap":34608347},{"date":"2022-02-18","current":-3.003721,"twenty":-4.232683,"median":-0.896124,"eighty":-0.554405,"marketCap":33380351},{"date":"2022-02-25","current":-2.82787,"twenty":-4.218042,"median":-0.920532,"eighty":-0.554406,"marketCap":31426122},{"date":"2022-03-04","current":-2.881338,"twenty":-4.112294,"median":-0.956767,"eighty":-0.555309,"marketCap":32020313},{"date":"2022-03-11","current":-2.825494,"twenty":-4.099224,"median":-1.006209,"eighty":-0.555502,"marketCap":31399713},{"date":"2022-03-18","current":-4.775235,"twenty":-4.099224,"median":-1.037737,"eighty":-0.556101,"marketCap":68128271},{"date":"2022-03-25","current":-3.919024,"twenty":-4.099224,"median":-1.064779,"eighty":-0.556465,"marketCap":55912713},{"date":"2022-04-01","current":-3.194965,"twenty":-4.099224,"median":-1.08458,"eighty":-0.556893,"marketCap":45582566},{"date":"2022-04-08","current":-2.887351,"twenty":-4.063578,"median":-1.094696,"eighty":-0.558899,"marketCap":41193838},{"date":"2022-04-14","current":-2.942877,"twenty":-4.016051,"median":-1.111061,"eighty":-0.559105,"marketCap":41986027},{"date":"2022-04-22","current":-2.709668,"twenty":-3.997515,"median":-1.129172,"eighty":-0.559519,"marketCap":38658832},{"date":"2022-04-29","current":-2.653031,"twenty":-3.983495,"median":-1.139179,"eighty":-0.560037,"marketCap":37850799},{"date":"2022-05-06","current":-2.724105,"twenty":-3.949038,"median":-1.14331,"eighty":-0.560197,"marketCap":38864802},{"date":"2022-05-13","current":-2.54309,"twenty":-3.938819,"median":-1.151205,"eighty":-0.560273,"marketCap":36282265},{"date":"2022-05-20","current":-2.161146,"twenty":-3.926343,"median":-1.156529,"eighty":-0.56058,"marketCap":34586980},{"date":"2022-05-27","current":-2.159166,"twenty":-3.919894,"median":-1.156897,"eighty":-0.561617,"marketCap":34555292},{"date":"2022-06-03","current":-2.133426,"twenty":-3.909696,"median":-1.165802,"eighty":-0.56225,"marketCap":34143354},{"date":"2022-06-10","current":-2.078977,"twenty":-3.896879,"median":-1.16828,"eighty":-0.56264,"marketCap":33271946},{"date":"2022-06-17","current":-1.864149,"twenty":-3.879648,"median":-1.175074,"eighty":-0.563105,"marketCap":29833845},{"date":"2022-06-24","current":-1.918599,"twenty":-3.870143,"median":-1.182994,"eighty":-0.563591,"marketCap":30705253},{"date":"2022-07-01","current":-2.276975,"twenty":-3.861743,"median":-1.193251,"eighty":-0.564291,"marketCap":36440703},{"date":"2022-07-08","current":-2.351224,"twenty":-3.850491,"median":-1.193434,"eighty":-0.56495,"marketCap":37628987},{"date":"2022-07-15","current":-1.613682,"twenty":-3.844122,"median":-1.200778,"eighty":-0.565523,"marketCap":25825367},{"date":"2022-07-22","current":-1.534483,"twenty":-3.830182,"median":-1.211611,"eighty":-0.565679,"marketCap":24557865},{"date":"2022-07-29","current":-1.425584,"twenty":-3.824355,"median":-1.222168,"eighty":-0.565726,"marketCap":22815048},{"date":"2022-08-05","current":-1.435484,"twenty":-3.815486,"median":-1.229972,"eighty":-0.566106,"marketCap":22973486},{"date":"2022-08-12","current":-1.310163,"twenty":-3.80099,"median":-1.231807,"eighty":-0.567168,"marketCap":23290769},{"date":"2022-08-19","current":-1.336901,"twenty":-3.796,"median":-1.248516,"eighty":-0.56839,"marketCap":23766091},{"date":"2022-08-26","current":-1.354726,"twenty":-3.791193,"median":-1.256699,"eighty":-0.568728,"marketCap":24082972},{"date":"2022-09-02","current":-1.283425,"twenty":-3.766883,"median":-1.265958,"eighty":-0.568978,"marketCap":22815447},{"date":"2022-09-09","current":-1.274512,"twenty":-3.731346,"median":-1.2656,"eighty":-0.569201,"marketCap":22657007},{"date":"2022-09-16","current":-1.194298,"twenty":-3.702371,"median":-1.258398,"eighty":-0.569382,"marketCap":21231041},{"date":"2022-09-23","current":-0.944743,"twenty":-3.68336,"median":-1.248516,"eighty":-0.571834,"marketCap":16794704},{"date":"2022-09-30","current":-0.87879,"twenty":-3.680984,"median":-1.247774,"eighty":-0.572488,"marketCap":15622244},{"date":"2022-10-07","current":-0.944743,"twenty":-3.623359,"median":-1.238862,"eighty":-0.572707,"marketCap":16794704},{"date":"2022-10-14","current":-0.882444,"twenty":-3.598084,"median":-1.230155,"eighty":-0.573146,"marketCap":15687204},{"date":"2022-10-21","current":-0.819966,"twenty":-3.578801,"median":-1.229949,"eighty":-0.574242,"marketCap":14576536},{"date":"2022-10-28","current":-0.677363,"twenty":-3.562166,"median":-1.222168,"eighty":-0.575776,"marketCap":12041486},{"date":"2022-11-04","current":-0.643941,"twenty":-3.550284,"median":-1.211611,"eighty":-0.57763,"marketCap":11447334},{"date":"2022-11-11","current":-0.504821,"twenty":-3.533232,"median":-1.20188,"eighty":-0.575776,"marketCap":9771824},{"date":"2022-11-18","current":-0.572963,"twenty":-3.505133,"median":-1.198208,"eighty":-0.572707,"marketCap":11090842},{"date":"2022-11-25","current":-0.570917,"twenty":-3.42425,"median":-1.193434,"eighty":-0.571651,"marketCap":11051232},{"date":"2022-12-02","current":-0.589333,"twenty":-3.403021,"median":-1.191874,"eighty":-0.572357,"marketCap":11407723},{"date":"2022-12-09","current":-0.487591,"twenty":-3.400752,"median":-1.177694,"eighty":-0.569346,"marketCap":9438307},{"date":"2022-12-16","current":-0.459925,"twenty":-3.391351,"median":-1.174155,"eighty":-0.56803,"marketCap":8902777},{"date":"2022-12-23","current":-0.328234,"twenty":-3.388948,"median":-1.165893,"eighty":-0.56564,"marketCap":6353618},{"date":"2022-12-30","current":-0.355345,"twenty":-3.385925,"median":-1.16571,"eighty":-0.563708,"marketCap":6878422},{"date":"2023-01-06","current":-0.453167,"twenty":-3.379661,"median":-1.156529,"eighty":-0.561376,"marketCap":8771955},{"date":"2023-01-13","current":-0.531221,"twenty":-3.359732,"median":-1.147716,"eighty":-0.55993,"marketCap":10282849},{"date":"2023-01-20","current":-0.59693,"twenty":-3.359732,"median":-1.138353,"eighty":-0.55993,"marketCap":11554782},{"date":"2023-01-27","current":-0.707096,"twenty":-3.331421,"median":-1.101632,"eighty":-0.55993,"marketCap":13687260},{"date":"2023-02-03","current":-0.836015,"twenty":-3.315024,"median":-1.078434,"eighty":-0.55993,"marketCap":16182745},{"date":"2023-02-10","current":-0.812575,"twenty":-3.315024,"median":-1.037737,"eighty":-0.55993,"marketCap":15729023},{"date":"2023-02-17","current":-0.764758,"twenty":-3.315024,"median":-1.016045,"eighty":-0.55993,"marketCap":14803430},{"date":"2023-02-24","current":-0.735225,"twenty":-3.315024,"median":-0.956767,"eighty":-0.55993,"marketCap":14231741},{"date":"2023-03-03","current":-0.673813,"twenty":-3.305797,"median":-0.938905,"eighty":-0.55993,"marketCap":13042990},{"date":"2023-03-10","current":-0.578179,"twenty":-3.302932,"median":-0.918451,"eighty":-0.55993,"marketCap":11191820},{"date":"2023-03-17","current":-0.593805,"twenty":-3.289122,"median":-0.901567,"eighty":-0.55993,"marketCap":11494286},{"date":"2023-03-24","current":-0.483561,"twenty":-3.289122,"median":-0.880893,"eighty":-0.55886,"marketCap":9360281},{"date":"2023-03-31","current":-0.536583,"twenty":-3.284844,"median":-0.860364,"eighty":-0.555981,"marketCap":10562644},{"date":"2023-04-06","current":-0.537736,"twenty":-3.284844,"median":-0.849689,"eighty":-0.554406,"marketCap":10585330},{"date":"2023-04-14","current":-0.545496,"twenty":-3.289122,"median":-0.836015,"eighty":-0.553272,"marketCap":10738083},{"date":"2023-04-21","current":-0.545496,"twenty":-3.289122,"median":-0.822344,"eighty":-0.552002,"marketCap":10738083},{"date":"2023-04-28","current":-0.50831,"twenty":-3.289122,"median":-0.816188,"eighty":-0.548963,"marketCap":10006078},{"date":"2023-05-05","current":-0.560862,"twenty":-3.289122,"median":-0.805845,"eighty":-0.546872,"marketCap":11040564},{"date":"2023-05-12","current":-0.529208,"twenty":-3.289122,"median":-0.789136,"eighty":-0.546322,"marketCap":10417453},{"date":"2023-05-19","current":-0.539873,"twenty":-3.289122,"median":-0.786548,"eighty":-0.545058,"marketCap":10738083},{"date":"2023-05-26","current":-0.504896,"twenty":-3.289122,"median":-0.771626,"eighty":-0.543556,"marketCap":10042376},{"date":"2023-06-02","current":-0.485962,"twenty":-3.293399,"median":-0.76666,"eighty":-0.54247,"marketCap":9665787},{"date":"2023-06-08","current":-0.533866,"twenty":-3.297677,"median":-0.764433,"eighty":-0.542403,"marketCap":10618603},{"date":"2023-06-16","current":-0.53227,"twenty":-3.301954,"median":-0.758263,"eighty":-0.540326,"marketCap":10586842},{"date":"2023-06-23","current":-0.502158,"twenty":-3.303142,"median":-0.752851,"eighty":-0.538322,"marketCap":9987929},{"date":"2023-06-30","current":-0.699554,"twenty":-3.30433,"median":-0.747625,"eighty":-0.537275,"marketCap":13914136},{"date":"2023-07-07","current":-0.623592,"twenty":-3.30433,"median":-0.742349,"eighty":-0.537275,"marketCap":12403242},{"date":"2023-07-14","current":-0.553941,"twenty":-3.30433,"median":-0.735004,"eighty":-0.537275,"marketCap":11017878},{"date":"2023-07-21","current":-0.539113,"twenty":-3.30433,"median":-0.729628,"eighty":-0.536494,"marketCap":10722959},{"date":"2023-07-28","current":-0.481324,"twenty":-3.30433,"median":-0.724498,"eighty":-0.534659,"marketCap":9573530},{"date":"2023-08-04","current":-0.49425,"twenty":-3.30433,"median":-0.720134,"eighty":-0.53286,"marketCap":9830639},{"date":"2023-08-11","current":-0.53295,"twenty":-3.30433,"median":-0.717872,"eighty":-0.53227,"marketCap":10924412},{"date":"2023-08-18","current":-0.440744,"twenty":-3.30433,"median":-0.716071,"eighty":-0.531268,"marketCap":9034369},{"date":"2023-08-25","current":-0.436504,"twenty":-3.30433,"median":-0.714981,"eighty":-0.528148,"marketCap":8947451},{"date":"2023-09-01","current":-0.436504,"twenty":-3.30433,"median":-0.711312,"eighty":-0.523809,"marketCap":8947451},{"date":"2023-09-08","current":-0.422369,"twenty":-3.30433,"median":-0.709081,"eighty":-0.522306,"marketCap":8657724},{"date":"2023-09-15","current":-0.447479,"twenty":-3.30433,"median":-0.709081,"eighty":-0.517062,"marketCap":9172416},{"date":"2023-09-22","current":-0.430517,"twenty":-3.30433,"median":-0.709081,"eighty":-0.514706,"marketCap":8824743},{"date":"2023-09-29","current":-0.415801,"twenty":-3.305519,"median":-0.711004,"eighty":-0.51278,"marketCap":8523086},{"date":"2023-10-06","current":-0.407403,"twenty":-3.305519,"median":-0.705538,"eighty":-0.509488,"marketCap":8350954},{"date":"2023-10-13","current":-0.394932,"twenty":-3.305519,"median":-0.70319,"eighty":-0.508104,"marketCap":8095313},{"date":"2023-10-20","current":-0.374146,"twenty":-3.305519,"median":-0.70319,"eighty":-0.507081,"marketCap":7669244},{"date":"2023-10-27","current":-0.374146,"twenty":-3.31146,"median":-0.703469,"eighty":-0.505133,"marketCap":7669244},{"date":"2023-11-03","current":-0.374146,"twenty":-3.31146,"median":-0.703469,"eighty":-0.503666,"marketCap":7669244},{"date":"2023-11-10","current":-0.374146,"twenty":-3.31146,"median":-0.70319,"eighty":-0.501843,"marketCap":7669244},{"date":"2023-11-17","current":-0.351002,"twenty":-3.31146,"median":-0.697375,"eighty":-0.499296,"marketCap":6650086},{"date":"2023-11-24","current":-0.474857,"twenty":-3.31146,"median":-0.691269,"eighty":-0.497519,"marketCap":9169007},{"date":"2023-12-01","current":-0.528697,"twenty":-3.31146,"median":-0.684846,"eighty":-0.496211,"marketCap":10208616},{"date":"2023-12-08","current":-0.52958,"twenty":-3.307895,"median":-0.679746,"eighty":-0.496235,"marketCap":10225659},{"date":"2023-12-15","current":-0.518547,"twenty":-3.307895,"median":-0.675604,"eighty":-0.494662,"marketCap":10012624},{"date":"2023-12-22","current":-0.450143,"twenty":-3.307895,"median":-0.673813,"eighty":-0.494275,"marketCap":8691810},{"date":"2023-12-29","current":-0.390036,"twenty":-3.31146,"median":-0.671761,"eighty":-0.494091,"marketCap":7531197},{"date":"2024-01-05","current":-0.394272,"twenty":-3.315024,"median":-0.66912,"eighty":-0.493262,"marketCap":7613003},{"date":"2024-01-12","current":-0.370794,"twenty":-3.315024,"median":-0.668011,"eighty":-0.491925,"marketCap":7159665},{"date":"2024-01-19","current":-0.366293,"twenty":-3.318589,"median":-0.667779,"eighty":-0.490835,"marketCap":7072747},{"date":"2024-01-26","current":-0.372824,"twenty":-3.315024,"median":-0.664015,"eighty":-0.4874,"marketCap":7198863},{"date":"2024-02-02","current":-0.455086,"twenty":-3.315024,"median":-0.660462,"eighty":-0.48591,"marketCap":8787249},{"date":"2024-02-09","current":-0.472562,"twenty":-3.315024,"median":-0.658221,"eighty":-0.484311,"marketCap":9124696},{"date":"2024-02-16","current":-0.41572,"twenty":-3.315024,"median":-0.656727,"eighty":-0.483435,"marketCap":8027142},{"date":"2024-02-23","current":-0.433285,"twenty":-3.315024,"median":-0.655171,"eighty":-0.482634,"marketCap":8366293},{"date":"2024-03-01","current":-0.410424,"twenty":-3.31146,"median":-0.652353,"eighty":-0.480846,"marketCap":7924885},{"date":"2024-03-08","current":-0.406011,"twenty":-3.31146,"median":-0.649964,"eighty":-0.476369,"marketCap":7839671},{"date":"2024-03-15","current":-0.364616,"twenty":-3.31146,"median":-0.648423,"eighty":-0.474686,"marketCap":7040366},{"date":"2024-03-22","current":-0.443876,"twenty":-3.31146,"median":-0.645425,"eighty":-0.47327,"marketCap":8570806},{"date":"2024-03-28","current":-0.452789,"twenty":-3.31146,"median":-0.644454,"eighty":-0.471532,"marketCap":8308229},{"date":"2024-04-05","current":-0.401856,"twenty":-3.315024,"median":-0.641005,"eighty":-0.468806,"marketCap":7373661},{"date":"2024-04-12","current":-0.411202,"twenty":-3.315024,"median":-0.63863,"eighty":-0.465918,"marketCap":7545141},{"date":"2024-04-19","current":-0.418678,"twenty":-3.315024,"median":-0.636957,"eighty":-0.462258,"marketCap":7682325},{"date":"2024-04-26","current":-0.383119,"twenty":-3.31146,"median":-0.634914,"eighty":-0.458969,"marketCap":7029842},{"date":"2024-05-03","current":-0.390642,"twenty":-3.31146,"median":-0.632448,"eighty":-0.457367,"marketCap":7167884},{"date":"2024-05-10","current":-0.363932,"twenty":-3.31146,"median":-0.631649,"eighty":-0.455239,"marketCap":6927811},{"date":"2024-05-17","current":-0.336907,"twenty":-3.31146,"median":-0.627161,"eighty":-0.452468,"marketCap":6413370},{"date":"2024-05-24","current":-0.300421,"twenty":-3.31146,"median":-0.62339,"eighty":-0.450143,"marketCap":5718809},{"date":"2024-05-31","current":-0.242606,"twenty":-3.31146,"median":-0.62339,"eighty":-0.449152,"marketCap":4618241},{"date":"2024-06-07","current":-0.242787,"twenty":-3.31146,"median":-0.62339,"eighty":-0.446856,"marketCap":4621696},{"date":"2024-06-14","current":-0.218735,"twenty":-3.315024,"median":-0.623592,"eighty":-0.443857,"marketCap":4163846},{"date":"2024-06-21","current":-0.222547,"twenty":-3.318589,"median":-0.62339,"eighty":-0.441359,"marketCap":4236411},{"date":"2024-06-28","current":-0.220641,"twenty":-3.32857,"median":-0.625058,"eighty":-0.440638,"marketCap":4200128},{"date":"2024-07-05","current":-0.208752,"twenty":-3.32857,"median":-0.619265,"eighty":-0.43957,"marketCap":3973795},{"date":"2024-07-12","current":-0.23598,"twenty":-3.32857,"median":-0.616695,"eighty":-0.436682,"marketCap":4492116},{"date":"2024-07-15","current":-0.23598,"twenty":-3.32857,"median":-0.615556,"eighty":-0.436504,"marketCap":4492116},{"date":"2024-08-02","current":-0.198042,"twenty":-3.380136,"median":-0.617262,"eighty":-0.435015,"marketCap":3769922},{"date":"2024-08-09","current":-0.190599,"twenty":-3.380136,"median":-0.617262,"eighty":-0.432566,"marketCap":3628247},{"date":"2024-08-16","current":-0.154796,"twenty":-3.380136,"median":-0.617262,"eighty":-0.431604,"marketCap":3446835},{"date":"2024-08-23","current":-0.146835,"twenty":-3.380136,"median":-0.617262,"eighty":-0.430459,"marketCap":3269573},{"date":"2024-08-30","current":-0.212183,"twenty":-3.380136,"median":-0.617262,"eighty":-0.428972,"marketCap":4724670},{"date":"2024-09-06","current":-0.145368,"twenty":-3.380136,"median":-0.617262,"eighty":-0.427851,"marketCap":3236901},{"date":"2024-09-13","current":-0.162523,"twenty":-3.380136,"median":-0.617262,"eighty":-0.424552,"marketCap":3618896},{"date":"2024-09-20","current":-0.1711,"twenty":-3.380136,"median":-0.610449,"eighty":-0.423664,"marketCap":3809893},{"date":"2024-09-27","current":-0.124035,"twenty":-3.380136,"median":-0.610449,"eighty":-0.420134,"marketCap":2761878},{"date":"2024-10-04","current":-0.108834,"twenty":-3.380136,"median":-0.610449,"eighty":-0.418838,"marketCap":2423412},{"date":"2024-10-11","current":-0.159206,"twenty":-3.380136,"median":-0.610449,"eighty":-0.416624,"marketCap":3545040},{"date":"2024-10-18","current":-0.14798,"twenty":-3.380136,"median":-0.610449,"eighty":-0.415718,"marketCap":3295069},{"date":"2024-10-25","current":-0.153083,"twenty":-3.380136,"median":-0.610449,"eighty":-0.413435,"marketCap":3408693},{"date":"2024-10-31","current":-0.151042,"twenty":-3.380136,"median":-0.610449,"eighty":-0.411202,"marketCap":3363243},{"date":"2024-11-08","current":-0.220439,"twenty":-3.380374,"median":-0.611466,"eighty":-0.40952,"marketCap":4908517},{"date":"2024-11-15","current":-0.114938,"twenty":-3.380374,"median":-0.611466,"eighty":-0.407403,"marketCap":3067823},{"date":"2024-11-22","current":-0.125524,"twenty":-3.380374,"median":-0.611466,"eighty":-0.406011,"marketCap":3350351},{"date":"2024-11-29","current":-0.150115,"twenty":-3.380374,"median":-0.611466,"eighty":-0.405129,"marketCap":4006726},{"date":"2024-12-06","current":-0.134478,"twenty":-3.380374,"median":-0.611466,"eighty":-0.401856,"marketCap":3589359},{"date":"2024-12-13","current":-0.124054,"twenty":-3.380374,"median":-0.611466,"eighty":-0.398663,"marketCap":3311114},{"date":"2024-12-20","current":-0.119884,"twenty":-3.380374,"median":-0.611466,"eighty":-0.397185,"marketCap":3199816},{"date":"2024-12-27","current":-0.16471,"twenty":-3.380374,"median":-0.611466,"eighty":-0.396832,"marketCap":4396269},{"date":"2025-01-03","current":-0.172007,"twenty":-3.380374,"median":-0.611466,"eighty":-0.394932,"marketCap":4591040},{"date":"2025-01-10","current":-0.153243,"twenty":-3.381087,"median":-0.612657,"eighty":-0.392417,"marketCap":4090200},{"date":"2025-01-17","current":-0.149073,"twenty":-3.381087,"median":-0.612657,"eighty":-0.390751,"marketCap":3978902},{"date":"2025-01-24","current":-0.142818,"twenty":-3.381087,"median":-0.612657,"eighty":-0.389803,"marketCap":3811955},{"date":"2025-01-31","current":-0.133436,"twenty":-3.381087,"median":-0.612657,"eighty":-0.385763,"marketCap":3561534},{"date":"2025-02-07","current":-0.154285,"twenty":-3.381087,"median":-0.60887,"eighty":-0.382418,"marketCap":4118024},{"date":"2025-02-14","current":-0.179304,"twenty":-3.381087,"median":-0.607721,"eighty":-0.379483,"marketCap":4785812},{"date":"2025-02-21","current":-0.167837,"twenty":-3.381087,"median":-0.607721,"eighty":-0.376607,"marketCap":4479742},{"date":"2025-02-28","current":-0.145945,"twenty":-3.381087,"median":-0.607721,"eighty":-0.374146,"marketCap":3895428},{"date":"2025-03-07","current":-0.146988,"twenty":-3.3818,"median":-0.608308,"eighty":-0.373785,"marketCap":3923253},{"date":"2025-03-14","current":-0.120396,"twenty":-3.3818,"median":-0.608308,"eighty":-0.373039,"marketCap":3088518},{"date":"2025-03-21","current":-0.130158,"twenty":-3.3818,"median":-0.608308,"eighty":-0.373039,"marketCap":3338938},{"date":"2025-03-28","current":-0.131242,"twenty":-3.3818,"median":-0.608308,"eighty":-0.372688,"marketCap":3366763},{"date":"2025-04-04","current":-0.127989,"twenty":-3.3818,"median":-0.608308,"eighty":-0.372688,"marketCap":3283289},{"date":"2025-04-11","current":-0.126904,"twenty":-3.381087,"median":-0.607721,"eighty":-0.3724,"marketCap":3255465},{"date":"2025-04-17","current":-0.143195,"twenty":-3.381087,"median":-0.607721,"eighty":-0.370776,"marketCap":3673389},{"date":"2025-04-25","current":-0.153272,"twenty":-3.3818,"median":-0.608308,"eighty":-0.370706,"marketCap":3931878},{"date":"2025-05-02","current":-0.151851,"twenty":-3.3818,"median":-0.608308,"eighty":-0.366293,"marketCap":3895428},{"date":"2025-05-09","current":-0.069765,"twenty":-3.3818,"median":-0.608308,"eighty":-0.363401,"marketCap":1789671},{"date":"2025-05-16","current":-0.104097,"twenty":-3.3818,"median":-0.608308,"eighty":-0.357147,"marketCap":2582859},{"date":"2025-05-23","current":-0.089207,"twenty":-3.3818,"median":-0.608308,"eighty":-0.345815,"marketCap":2213401},{"date":"2025-05-30","current":-0.086956,"twenty":-3.3818,"median":-0.608308,"eighty":-0.336471,"marketCap":2157553},{"date":"2025-06-06","current":-0.155412,"twenty":-3.3818,"median":-0.608308,"eighty":-0.328428,"marketCap":3856071},{"date":"2025-06-13","current":-0.164848,"twenty":-3.3818,"median":-0.608308,"eighty":-0.307874,"marketCap":4090219},{"date":"2025-06-20","current":-0.148812,"twenty":-3.382513,"median":-0.607721,"eighty":-0.253225,"marketCap":3692332},{"date":"2025-06-27","current":-0.145249,"twenty":-3.382513,"median":-0.601576,"eighty":-0.23981,"marketCap":3603912},{"date":"2025-07-03","current":-0.161746,"twenty":-3.382513,"median":-0.592593,"eighty":-0.23598,"marketCap":4013243},{"date":"2025-07-11","current":-0.171641,"twenty":-3.382513,"median":-0.57922,"eighty":-0.227685,"marketCap":4258749},{"date":"2025-07-18","current":-0.17416,"twenty":-3.382513,"median":-0.575195,"eighty":-0.221331,"marketCap":4321253},{"date":"2025-07-25","current":-0.18033,"twenty":-3.382513,"median":-0.567502,"eighty":-0.218282,"marketCap":4474354},{"date":"2025-08-01","current":-0.162914,"twenty":-3.382513,"median":-0.563857,"eighty":-0.21025,"marketCap":4042229},{"date":"2025-08-08","current":-0.142395,"twenty":-3.382513,"median":-0.559832,"eighty":-0.201865,"marketCap":3533100},{"date":"2025-08-15","current":-0.141271,"twenty":-3.382513,"median":-0.552295,"eighty":-0.197588,"marketCap":4175109},{"date":"2025-08-22","current":-0.139484,"twenty":-3.382513,"median":-0.546449,"eighty":-0.189036,"marketCap":4122320},{"date":"2025-08-29","current":-0.134386,"twenty":-3.382513,"median":-0.540844,"eighty":-0.185506,"marketCap":3971632},{"date":"2025-09-05","current":-0.126721,"twenty":-3.383226,"median":-0.539113,"eighty":-0.183327,"marketCap":3745120},{"date":"2025-09-12","current":-0.136594,"twenty":-3.382513,"median":-0.536517,"eighty":-0.180793,"marketCap":4036898},{"date":"2025-09-19","current":-0.134158,"twenty":-3.382513,"median":-0.534056,"eighty":-0.178011,"marketCap":3964913},{"date":"2025-09-26","current":-0.126526,"twenty":-3.382513,"median":-0.53303,"eighty":-0.175763,"marketCap":3739362},{"date":"2025-10-03","current":-0.131852,"twenty":-3.382513,"median":-0.53227,"eighty":-0.172728,"marketCap":3896768},{"date":"2025-10-10","current":-0.15897,"twenty":-3.382513,"median":-0.53227,"eighty":-0.171412,"marketCap":4698197},{"date":"2025-10-17","current":-0.140004,"twenty":-3.382513,"median":-0.53227,"eighty":-0.170011,"marketCap":4137677},{"date":"2025-10-24","current":-0.111068,"twenty":-3.382513,"median":-0.53227,"eighty":-0.166945,"marketCap":3282499},{"date":"2025-10-31","current":-0.105222,"twenty":-3.382513,"median":-0.53227,"eighty":-0.163465,"marketCap":3109736},{"date":"2025-11-07","current":-0.088757,"twenty":-3.382513,"median":-0.53227,"eighty":-0.161746,"marketCap":2623120},{"date":"2025-11-14","current":-0.313947,"twenty":-3.382513,"median":-0.531784,"eighty":-0.161746,"marketCap":9278401},{"date":"2025-11-21","current":-0.276075,"twenty":-3.382513,"median":-0.52958,"eighty":-0.161746,"marketCap":7230405},{"date":"2025-11-28","current":-0.347703,"twenty":-3.382513,"median":-0.526633,"eighty":-0.161746,"marketCap":9106329},{"date":"2025-12-05","current":-0.311245,"twenty":-3.382513,"median":-0.522447,"eighty":-0.161746,"marketCap":8151497},{"date":"2025-12-12","current":-0.29965,"twenty":-3.382513,"median":-0.518527,"eighty":-0.161746,"marketCap":7847840},{"date":"2025-12-19","current":-0.225575,"twenty":-3.382513,"median":-0.514773,"eighty":-0.161746,"marketCap":5907811},{"date":"2025-12-26","current":-0.250696,"twenty":-3.382513,"median":-0.51073,"eighty":-0.161746,"marketCap":6565734},{"date":"2026-01-02","current":-0.271051,"twenty":-3.382513,"median":-0.509351,"eighty":-0.161746,"marketCap":7098820},{"date":"2026-01-09","current":-0.282645,"twenty":-3.382513,"median":-0.506297,"eighty":-0.161746,"marketCap":7402477},{"date":"2026-01-16","current":-0.282117,"twenty":-3.382513,"median":-0.503101,"eighty":-0.161746,"marketCap":7388656},{"date":"2026-01-23","current":-0.281709,"twenty":-3.382513,"median":-0.502006,"eighty":-0.161746,"marketCap":7377958},{"date":"2026-01-30","current":-0.253933,"twenty":-3.334273,"median":-0.494301,"eighty":-0.161746,"marketCap":6650504},{"date":"2026-02-06","current":-0.272178,"twenty":-3.252764,"median":-0.492695,"eighty":-0.161746,"marketCap":7128342},{"date":"2026-02-13","current":-0.245763,"twenty":-3.208088,"median":-0.491105,"eighty":-0.161746,"marketCap":6436546},{"date":"2026-02-20","current":-0.267821,"twenty":-3.135609,"median":-0.486305,"eighty":-0.161746,"marketCap":7014231},{"date":"2026-02-27","current":-0.268229,"twenty":-3.106609,"median":-0.484264,"eighty":-0.161746,"marketCap":7024929},{"date":"2026-03-06","current":-0.251074,"twenty":-3.065031,"median":-0.475167,"eighty":-0.161746,"marketCap":6575619},{"date":"2026-03-13","current":-0.349693,"twenty":-2.974254,"median":-0.470717,"eighty":-0.161746,"marketCap":8301358},{"date":"2026-03-20","current":-0.358805,"twenty":-2.93252,"median":-0.461346,"eighty":-0.161746,"marketCap":8517679},{"date":"2026-03-27","current":-0.432654,"twenty":-2.899148,"median":-0.457248,"eighty":-0.161746,"marketCap":10270779}],"updateTime":1774830064898},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TOVX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2595780483","title":"Theriva™ Biologics Announces Positive Scientific Advice From the European Medicines Agency (Ema) on the Design of a Phase 3 Trial of Vcn-01 in Metastatic Pancreatic Ductal Adenocarcinoma (Pdac)","url":"https://stock-news.laohu8.com/highlight/detail?id=2595780483","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595780483?lang=en_us&edition=fundamental","pubTime":"2025-12-29 21:00","pubTimestamp":1767013200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nTUA8NP259:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TOVX","BK4139"],"gpt_icon":0},{"id":"2595578043","title":"Theriva Biologics Inc - to Schedule End-of-Phase 2 Meeting With FDA in H1 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2595578043","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595578043?lang=en_us&edition=fundamental","pubTime":"2025-12-29 21:00","pubTimestamp":1767013200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nTUA8NP259:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TOVX"],"gpt_icon":0},{"id":"2591273756","title":"Theriva Biologics Seeks Shareholder Approval for Issuance of 16.2 Million Shares Under Warrant Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2591273756","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591273756?lang=en_us&edition=fundamental","pubTime":"2025-12-16 06:22","pubTimestamp":1765837344,"startTime":"0","endTime":"0","summary":"Theriva Biologics Inc. announced that it was unable to convene its Special Meeting of Stockholders on December 15, 2025, due to a lack of quorum. The meeting was called to seek shareholder approval for the issuance of up to 16,184,560 shares of common stock upon the exercise of certain purchase warrants issued under a warrant inducement agreement with institutional investors. The company is required to call additional stockholder meetings every 60 days until approval is obtained or the warrants are no longer outstanding. The date and time of a new special meeting will be announced, and new proxy materials will be filed and mailed as required.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Theriva Biologics Inc. published the original c","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nNDL995W06:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TOVX"],"gpt_icon":0},{"id":"2582737149","title":"Theriva Biologics reports Q3 EPS (45c) vs ($6.81) last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2582737149","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582737149?lang=en_us&edition=fundamental","pubTime":"2025-11-12 21:16","pubTimestamp":1762953378,"startTime":"0","endTime":"0","summary":"“Recent presentations of clinical data for VCN-01 and preclinical data for VCN-12 at medical congresses have highlighted the progress made across o...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/theriva-biologics-reports-q3-eps-45c-vs-6-81-last-year-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/theriva-biologics-reports-q3-eps-45c-vs-6-81-last-year-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TOVX"],"gpt_icon":0},{"id":"2582716313","title":"Theriva Biologics Q3 EPS $(0.45) Beats $(1.13) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2582716313","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582716313?lang=en_us&edition=fundamental","pubTime":"2025-11-12 21:14","pubTimestamp":1762953243,"startTime":"0","endTime":"0","summary":"Theriva Biologics (AMEX:TOVX) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of $(1.13) by 60.18 percent. This is a 93.39 percent increase over losses of $(6.81) per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48800856/theriva-biologics-q3-eps-0-45-beats-1-13-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TOVX"],"gpt_icon":0},{"id":"2582797613","title":"Theriva Biologics reports third quarter loss and lower R&D expenses","url":"https://stock-news.laohu8.com/highlight/detail?id=2582797613","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582797613?lang=en_us&edition=fundamental","pubTime":"2025-11-12 21:02","pubTimestamp":1762952529,"startTime":"0","endTime":"0","summary":"Theriva Biologics Inc. reported cash and cash equivalents of $7.5 million as of September 30, 2025, compared to $11.6 million as of December 31, 2024. Following recent capital raises, cash increased to $15.5 million as of November 10, 2025, extending the cash runway into the first quarter of 2027. During the period, the company presented expanded Phase 2b clinical trial data for VCN-01 in metastatic pancreatic ductal adenocarcinoma at the European Society for Medical Oncology Annual Congress, and preclinical data for VCN-12 at the European Society of Gene & Cell Therapy Annual Congress. Theriva is preparing for regulatory discussions on a proposed Phase 3 study of VCN-01 in metastatic PDAC and a potential Phase 2/3 trial in retinoblastoma. Additional funding will be required to initiate new VCN-01 clinical trials.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this A","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDL1kXwfy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","BK4139","IE00BKPKM429.USD","LU0314104364.USD","BK4112","IE00B64PRP62.GBP","LU2095319765.USD","TOVX","BK4588","BK4585","NDAQ","IE00BGHQF748.EUR","LU2210150020.SGD","LU2210149790.SGD"],"gpt_icon":0},{"id":"2580154634","title":"Theriva Biologics Inc. Announces Date for Upcoming Special Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2580154634","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580154634?lang=en_us&edition=fundamental","pubTime":"2025-11-01 04:05","pubTimestamp":1761941157,"startTime":"0","endTime":"0","summary":"Theriva Biologics Inc. has announced that it will hold a Special Meeting of Stockholders on December 15, 2025, at its principal office in Rockville, Maryland.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Theriva Biologics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 31, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251031:nNDLc5Cvd6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TOVX"],"gpt_icon":0},{"id":"2578428995","title":"Theriva Biologics: No Material Development to Account for Stock Activity","url":"https://stock-news.laohu8.com/highlight/detail?id=2578428995","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578428995?lang=en_us&edition=fundamental","pubTime":"2025-10-25 03:01","pubTimestamp":1761332460,"startTime":"0","endTime":"0","summary":"Theriva Biologics, whose shares rose sharply Friday, said there has been no reason to account for the unusual market action.The company added that there wasn't any material development in its business and affairs not previously disclosed.Theriva's response to the unusual market action was pursuant to Section 401 of the NYSE Company Guide, it said.The stock was recently up 44%, to 49 cents, on volume of more than 479 million shares, compared with a 65-day average of 4.9 million shares.On Monday, expanded metastatic pancreatic ductal adenocarcinoma data from Theriva's VIRAGE Phase 2b trial was presented at the European Society for Medical Oncology Annual Congress.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TOVX"],"gpt_icon":0},{"id":"2578444645","title":"Theriva Biologics sees no material development to account for unusual trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2578444645","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578444645?lang=en_us&edition=fundamental","pubTime":"2025-10-25 02:40","pubTimestamp":1761331209,"startTime":"0","endTime":"0","summary":"Theriva Biologics (TOVX) announced that the company had become aware of unusual trading activity in its common stock on the NYSE American on Octobe...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/theriva-biologics-sees-no-material-development-to-account-for-unusual-trading-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/theriva-biologics-sees-no-material-development-to-account-for-unusual-trading-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TOVX","BK4139"],"gpt_icon":0},{"id":"2578826542","title":"Theriva Biologics Provides Response to Unusual Market Action","url":"https://stock-news.laohu8.com/highlight/detail?id=2578826542","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578826542?lang=en_us&edition=fundamental","pubTime":"2025-10-25 02:31","pubTimestamp":1761330660,"startTime":"0","endTime":"0","summary":"ROCKVILLE, Md., Oct.  24, 2025  (GLOBE NEWSWIRE) -- Theriva Biologics (NYSE American: TOVX), (“Theriva” or the “Company”), a diversified clinical-stage company developing therapeutics designed to trea","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/24/3173023/0/en/Theriva-Biologics-Provides-Response-to-Unusual-Market-Action.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TOVX"],"gpt_icon":0},{"id":"2577860959","title":"Theriva Biologics Presents Promising Phase 2b Trial Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2577860959","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577860959?lang=en_us&edition=fundamental","pubTime":"2025-10-21 02:50","pubTimestamp":1760986213,"startTime":"0","endTime":"0","summary":"Theriva Biologics ( ($TOVX) ) has provided an update. On October 20, 2025, Theriva Biologics presented expanded data from their VIRAGE Phase 2b tri...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/theriva-biologics-presents-promising-phase-2b-trial-data-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/theriva-biologics-presents-promising-phase-2b-trial-data-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TOVX","BK4139"],"gpt_icon":0},{"id":"2576046062","title":"Theriva Biologics Secures $4M Through Warrant Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2576046062","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576046062?lang=en_us&edition=fundamental","pubTime":"2025-10-18 05:49","pubTimestamp":1760737789,"startTime":"0","endTime":"0","summary":"Theriva Biologics ( ($TOVX) ) has shared an update. On October 16, 2025, Theriva Biologics entered into a warrant inducement agreement with existin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/theriva-biologics-secures-4m-through-warrant-agreement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/theriva-biologics-secures-4m-through-warrant-agreement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TOVX","BK4139"],"gpt_icon":0},{"id":"2576424064","title":"Theriva Biologics Raises $4 Million Through Warrant Inducement Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2576424064","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576424064?lang=en_us&edition=fundamental","pubTime":"2025-10-18 05:20","pubTimestamp":1760736007,"startTime":"0","endTime":"0","summary":"Theriva Biologics Inc. has announced a warrant inducement transaction with existing institutional investors, resulting in approximately $4.0 million in gross proceeds. Investors immediately exercised warrants to purchase up to 7,360,460 shares of common stock at a reduced exercise price of $0.54 per share. In exchange, these investors will receive new unregistered warrants to purchase up to 14,720,920 additional shares at the same exercise price. The new warrants will become exercisable upon stockholder approval and will expire five years after approval. Theriva Biologics intends to use the net proceeds for working capital and general corporate purposes. A.G.P./Alliance Global Partners served as exclusive financial advisor for the transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251017:nNDL2nVwjZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TOVX","BK4139"],"gpt_icon":0},{"id":"2575466087","title":"Theriva Biologics announces warrant inducement transaction for $4M in proceeds","url":"https://stock-news.laohu8.com/highlight/detail?id=2575466087","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575466087?lang=en_us&edition=fundamental","pubTime":"2025-10-16 20:20","pubTimestamp":1760617241,"startTime":"0","endTime":"0","summary":"Theriva Biologics (TOVX) announced its entry into a warrant inducement agreement with existing institutional investors of the Company for the immed...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/theriva-biologics-announces-warrant-inducement-transaction-for-4m-in-proceeds-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/theriva-biologics-announces-warrant-inducement-transaction-for-4m-in-proceeds-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TOVX"],"gpt_icon":0},{"id":"2573267401","title":"Theriva Biologics Announces New Preclinical Data and Next-Generation Oncolytic Adenovirus VCN-12 at ESGCT Congress, Highlighting Advances in Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2573267401","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573267401?lang=en_us&edition=fundamental","pubTime":"2025-10-06 20:11","pubTimestamp":1759752668,"startTime":"0","endTime":"0","summary":"Theriva Biologics Announces New Preclinical Data and Next-Generation Oncolytic Adenovirus VCN-12 at ESGCT Congress, Highlighting Advances in Cancer Treatment. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Theriva Biologics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 06, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nNDL9n2f7y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TOVX","BK4139"],"gpt_icon":0},{"id":"2572952397","title":"Theriva Biologics Restructures, Cuts Workforce by 32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2572952397","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572952397?lang=en_us&edition=fundamental","pubTime":"2025-10-03 04:39","pubTimestamp":1759437566,"startTime":"0","endTime":"0","summary":"Theriva Biologics ( ($TOVX) ) has issued an update. On September 28, 2025, Theriva Biologics‘ Board of Directors approved a restructuring plan to f...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/theriva-biologics-restructures-cuts-workforce-by-32?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/theriva-biologics-restructures-cuts-workforce-by-32?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TOVX","BK4139"],"gpt_icon":0},{"id":"2572528796","title":"BRIEF-Theriva Biologics Implements 32% Workforce Reduction - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2572528796","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572528796?lang=en_us&edition=fundamental","pubTime":"2025-10-03 04:26","pubTimestamp":1759436767,"startTime":"0","endTime":"0","summary":"BRIEF-Theriva Biologics Implements 32% Workforce Reduction - SEC FilingOct 2  - Theriva Biologics Inc TOVX.A:THERIVA BIOLOGICS INC - APPROVES PLAN TO RESTRUCTURE COMPANY - SEC FILINGTHERIVA BIOLOGICS INC - IMPLEMENTS 32% WORKFORCE REDUCTION - SEC FILINGTHERIVA BIOLOGICS INC: EXPECTS WILL EXTEND ITS CASH RUNWAY INTO Q2 OF 2026Source text: [ID:n0001104659-25-096047]Further company coverage: TOVX.A ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251002:nFWN3VJ0JG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TOVX"],"gpt_icon":0},{"id":"2572855528","title":"Theriva Biologics Inc: Expects Will Extend Its Cash Runway Into Q2 of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2572855528","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572855528?lang=en_us&edition=fundamental","pubTime":"2025-10-03 04:02","pubTimestamp":1759435362,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251002:nFWN3VJ0JG:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TOVX","BK4139"],"gpt_icon":0},{"id":"2572528831","title":"Theriva Biologics Announces Corporate Reorganization, Cuts Workforce by 32% to Focus on Clinical Trials and Licensing Activities","url":"https://stock-news.laohu8.com/highlight/detail?id=2572528831","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572528831?lang=en_us&edition=fundamental","pubTime":"2025-10-03 04:02","pubTimestamp":1759435324,"startTime":"0","endTime":"0","summary":"Theriva Biologics Announces Corporate Reorganization, Cuts Workforce by 32% to Focus on Clinical Trials and Licensing Activities. **Theriva Biologics Announces Corporate Reorganization and Workforce Reduction** Theriva Biologics Inc. has announced a significant corporate reorganization aimed at focusing its efforts on business development, licensing activities, and advancing clinical trials for its lead product candidate, VCN-01. As part of the restructuring plan approved by the Board of Directors on September 28, 2025, the company implemented a workforce reduction of approximately 32%, affecting about seven employees. The move is expected to save Theriva around $2 million annually in compensation and benefits, with total restructuring charges estimated at $520,000 to be incurred in the fourth quarter of 2025. The company believes these changes will extend its cash runway into the second quarter of 2026 and better position it for upcoming regulatory meetings and planned clinical trials","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251002:nNDLv97rn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TOVX"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":39,"code":"91000000","status":"200"}]}}